AMDUF vs. IBRX
AMDUF (Amundi SA) and IBRX (ImmunityBio, Inc.) are both stocks. AMDUF operates in Asset Management (Financial Services), while IBRX operates in Biotechnology (Healthcare). Over the past 5 years, AMDUF returned 4.93%/yr vs -8.14%/yr for IBRX. Their 0.01 correlation means their historical movements had little consistent relationship.
Performance
AMDUF vs. IBRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMDUF achieves a 30.93% return, which is significantly lower than IBRX's 262.12% return.
AMDUF
- 1D
- -4.57%
- 1M
- 26.70%
- 6M
- 26.70%
- YTD
- 30.93%
- 1Y
- 31.02%
- 3Y*
- 20.61%
- 5Y*
- 4.93%
- 10Y*
- —
- ALL TIME*
- 9.20%
IBRX
- 1D
- -3.76%
- 1M
- -24.05%
- 6M
- 14.72%
- YTD
- 262.12%
- 1Y
- 202.53%
- 3Y*
- 52.04%
- 5Y*
- -8.14%
- 10Y*
- -0.45%
- ALL TIME*
- -13.85%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
AMDUF Amundi SA | $3.87K | $1.85K | $691.23 |
| $66.22M | $77.42M | $99.59M |
AMDUF vs. IBRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
AMDUF Amundi SA | 30.93% | 25.73% | 19.31% | -4.64% | -32.67% | 0.84% | 37.54% |
IBRX ImmunityBio, Inc. | 262.12% | -22.66% | -49.00% | -0.99% | -16.61% | -54.39% | 372.70% |
Correlation
The correlation between AMDUF and IBRX is 0.09, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.09 |
Correlation (3Y) Balances recent behavior with more history. | 0.00 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.02 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2020 | 0.01 |
Fundamentals
AMDUF:
$16.88B
IBRX:
$7.51B
AMDUF:
€15.01
IBRX:
-$0.87
AMDUF:
1.78
IBRX:
50.23
AMDUF:
€9.84B
IBRX:
$140.98M
AMDUF:
€6.86B
IBRX:
$132.23M
AMDUF:
€2.97B
IBRX:
-$196.14M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMDUF vs. IBRX — Risk / Return Rank
AMDUF
IBRX
AMDUF vs. IBRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi SA (AMDUF) and ImmunityBio, Inc. (IBRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMDUF | IBRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.89 | ||
| Sortino ratioReturn per unit of downside risk | +4.07 | ||
| Omega ratioGain probability vs. loss probability | 7.91 | 1.35 | +6.57 |
| Calmar ratioReturn relative to maximum drawdown | 6.91 | 4.55 | +2.36 |
| Martin ratioReturn relative to average drawdown | 108.83 | 7.64 | +101.18 |
Loading charts...
Drawdowns
AMDUF vs. IBRX - Drawdown Comparison
The maximum AMDUF drawdown since its inception was -53.45%, smaller than the maximum IBRX drawdown of -97.30%. Use the drawdown chart below to compare losses from any high point for AMDUF and IBRX.
Loading charts...
Drawdown Indicators
| AMDUF | IBRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -53.45% | -97.30% | +43.85% |
Max Drawdown (1Y)Largest decline over 1 year | -4.57% | -42.34% | +37.77% |
Max Drawdown (3Y)Largest decline over 3 years | -15.11% | -79.34% | +64.23% |
Max Drawdown (5Y)Largest decline over 5 years | -53.45% | -89.36% | +35.91% |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.03% | — |
Current DrawdownCurrent decline from peak | -4.57% | -83.03% | +78.46% |
Average DrawdownAverage peak-to-trough decline | -19.35% | -84.35% | +65.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.29% | 25.17% | -24.88% |
Volatility
AMDUF vs. IBRX - Volatility Comparison
Amundi SA (AMDUF) has a higher volatility of 28.96% compared to ImmunityBio, Inc. (IBRX) at 19.37%. This indicates that AMDUF's price experiences larger fluctuations and is considered to be riskier than IBRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMDUF | IBRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.96% | 19.37% | +9.59% |
Volatility (6M)Calculated over the trailing 6-month period | 28.77% | 75.25% | -46.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.46% | 105.40% | -71.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 32.25% | 113.61% | -81.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 31.12% | 111.43% | -80.31% |
Dividends
AMDUF vs. IBRX - Dividend Comparison
Neither AMDUF nor IBRX has paid dividends to shareholders.
Financials
AMDUF vs. IBRX - Financials Comparison
This section allows you to compare key financial metrics between Amundi SA and ImmunityBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AMDUF and IBRX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMDUF has higher volatility (28.96%) compared to IBRX (19.37%). In terms of maximum drawdown, AMDUF dropped -53.45% vs IBRX's -97.30%.
IBRX currently has the higher Sharpe Ratio (1.83 vs 0.94), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMDUF and IBRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer